Tango Therapeutics annual operating expenses
2020
2021
2022
2023
2024
2025
Tango Therapeutics Operating Expenses Growth & History (TNGX)
Tango Therapeutics's operating expenses was $173.7M for fiscal 2025.
View full Tango Therapeutics company overviewTango Therapeutics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $173.7M | −$14.0M | −7.46% |
| 2024 | 2024-12-31 | $187.7M | $37.0M | +24.53% |
| 2023 | 2023-12-31 | $150.7M | $14.8M | +10.87% |
| 2022 | 2022-12-31 | $135.9M | $40.7M | +42.74% |
| 2021 | 2021-12-31 | $95.2M | $35.4M | +59.10% |
| 2020 | 2020-12-31 | $59.9M | — | — |
Tango Therapeutics quarterly operating expenses
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $59.8M | $15.6M | +35.42% |
| Q1 2026 | 2026-03-31 | $48.8M | $847,000 | +1.77% |
| Q4 2025 | 2025-12-31 | $41.9M | −$3.2M | −7.02% |
| Q3 2025 | 2025-09-30 | $39.7M | −$4.7M | −10.67% |
| Q2 2025 | 2025-06-30 | $44.1M | −$5.3M | −10.68% |
| Q1 2025 | 2025-03-31 | $47.9M | −$804,000 | −1.65% |
| Q4 2024 | 2024-12-31 | $45.0M | $4.6M | +11.33% |
| Q3 2024 | 2024-09-30 | $44.5M | $8.1M | +22.35% |
| Q2 2024 | 2024-06-30 | $49.4M | $11.6M | +30.60% |
| Q1 2024 | 2024-03-31 | $48.7M | $12.7M | +35.15% |
| Q4 2023 | 2023-12-31 | $40.4M | $3.5M | +9.38% |
| Q3 2023 | 2023-09-30 | $36.4M | −$485,000 | −1.32% |
| Q2 2023 | 2023-06-30 | $37.8M | $6.9M | +22.19% |
| Q1 2023 | 2023-03-31 | $36.1M | $4.9M | +15.79% |
| Q4 2022 | 2022-12-31 | $37.0M | $9.3M | +33.49% |
| Q3 2022 | 2022-09-30 | $36.8M | $10.5M | +39.79% |
| Q2 2022 | 2022-06-30 | $31.0M | $8.3M | +36.39% |
| Q1 2022 | 2022-03-31 | $31.1M | $12.7M | +68.61% |
| Q4 2021 | 2021-12-31 | $27.7M | — | — |
| Q3 2021 | 2021-09-30 | $26.4M | $10.9M | +70.09% |
| Q2 2021 | 2021-06-30 | $22.7M | — | — |
| Q1 2021 | 2021-03-31 | $18.5M | — | — |
| Q3 2020 | 2020-09-30 | $15.5M | — | — |
Tango Therapeutics operating expenses trends
Over the last five fiscal years, Tango Therapeutics's operating expenses increased from $59.9M to $173.7M, a change of $113.8M. The latest reported quarter, Q2 2026, shows $59.8M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tango Therapeutics source filings ↗